{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:04:49Z","timestamp":1775581489665,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071214"],"award-info":[{"award-number":["82071214"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schizophr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Although MK801-induced NMDA receptor (NMDAR) hypofunction mimics schizophrenia symptoms, the exact factors causing NMDAR inhibition are unknown. Unexpectedly, external stress elicits formaldehyde (FA) generation; FA can induce depression and cognitive impairments by blocking NMDARs. This study explores using FA injection to establish a schizophrenia-like model in mice. Here, we reported that external stress-derived FA induces schizophrenia-like behaviors. Four experimental methods were used to induce schizophrenia-like symptoms in wild-type mice: double electrode stimulation of the ventral tegmental area (VTA), microinjection of FA or tetrahydroisoquinoline (TIQ) into the VTA, and intraperitoneal injection of MK801. Then the metabolic levels of FA and dopamine (DA) in the prefrontal cortex (PFC) and VTA were quantified using ELISA kits. We found that external stress-electrical stimulation via VTA caused schizophrenia-like behaviors, including despairing behavior as measured by the tail suspension test, anhedonia as evaluated by the sucrose preference test, stereotypical behavior as assessed by the marble burying test (MBT), anxiety-like behavior as measured by the open-field test and memory deficit as detected by the Y-maze. These behaviors correlated with increased DA and TIQ levels in the VTA and decreased DA levels in the PFC. High-resolution mass spectrometry (HRMS) and high-performance liquid chromatography (HPLC) confirmed TIQ formation from FA and DA. Furthermore, injecting TIQ into the VTA induced schizophrenia-like symptoms in mice, marked by higher FA and lower DA levels in the PFC than control mice. Strikingly, injecting FA into the VTA as well as administering MK-801 induced schizophrenia-like behaviors associated with reduced DA levels and low activity of tyrosine hydroxylase (TH) and monoamine oxidase (MAO) in the PFC. Hence, microinfusion of FA into the VTA can be used to prepare schizophrenia-like changes mouse model, suggesting that stress-derived FA may act as an endogenous trigger of schizophrenia-like changes.<\/jats:p>","DOI":"10.1038\/s41537-025-00603-3","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T20:44:14Z","timestamp":1743021854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["External stress, formaldehyde, and schizophrenia: a new mouse model for mental illness research"],"prefix":"10.1038","volume":"11","author":[{"given":"Junhao","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danrui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panpan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haishu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanjia","family":"Lyv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiangfeng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingzhou","family":"Lyv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8015-6299","authenticated-orcid":false,"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqian","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"603_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1176\/appi.ajp.2012.12050599","volume":"170","author":"C Crump","year":"2013","unstructured":"Crump, C., Winkleby, M. A., Sundquist, K. & Sundquist, J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am. J. Psychiatry 170, 324\u2013333 (2013).","journal-title":"Am. J. Psychiatry"},{"key":"603_CR2","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMra035458","volume":"349","author":"R Freedman","year":"2003","unstructured":"Freedman, R. Schizophrenia. N. Engl. J. Med. 349, 1738\u20131749 (2003).","journal-title":"N. Engl. J. Med."},{"key":"603_CR3","unstructured":"Organization, W. H. Schizophrenia. (World Health Organization, 2022)."},{"key":"603_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/YCO.0b013e32835035ca","volume":"25","author":"TM Laursen","year":"2012","unstructured":"Laursen, T. M., Munk-Olsen, T. & Vestergaard, M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr. Opin. Psychiatry 25, 83\u201388 (2012).","journal-title":"Curr. Opin. Psychiatry"},{"key":"603_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","volume":"10","author":"TM Laursen","year":"2014","unstructured":"Laursen, T. M., Nordentoft, M. & Mortensen, P. B. Excess early mortality in schizophrenia. Annu. Rev. Clin. Psychol. 10, 425\u2013448 (2014).","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"603_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/070674379704200204","volume":"42","author":"H H\u00e4fner","year":"1997","unstructured":"H\u00e4fner, H. & an der Heiden, W. Epidemiology of schizophrenia. Can. J. Psychiatry Rev. 42, 139\u2013151 (1997).","journal-title":"Can. J. Psychiatry Rev."},{"key":"603_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1517\/17460441.2015.976552","volume":"10","author":"M Bosia","year":"2015","unstructured":"Bosia, M., Pigoni, A. & Cavallaro, R. Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back. Expert Opin. Drug Discov. 10, 125\u2013139 (2015).","journal-title":"Expert Opin. Drug Discov."},{"key":"603_CR8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1021\/cn5003368","volume":"6","author":"M Moller","year":"2015","unstructured":"Moller, M., Swanepoel, T. & Harvey, B. H. Neurodevelopmental animal models reveal the convergent role of neurotransmitter systems, inflammation, and oxidative stress as biomarkers of schizophrenia: implications for novel drug development. ACS Chem. Neurosci. 6, 987\u20131016 (2015).","journal-title":"ACS Chem. Neurosci."},{"key":"603_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/0269881114563634","volume":"29","author":"O Howes","year":"2015","unstructured":"Howes, O., McCutcheon, R. & Stone, J. Glutamate and dopamine in schizophrenia: an update for the 21st century. J. Psychopharmacol. 29, 97\u2013115 (2015).","journal-title":"J. Psychopharmacol."},{"key":"603_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.biopsych.2015.07.025","volume":"79","author":"D Feifel","year":"2016","unstructured":"Feifel, D., Shilling, P. D. & MacDonald, K. A review of oxytocin\u2019s effects on the positive, negative, and cognitive domains of schizophrenia. Biol. Psychiatry 79, 222\u2013233 (2016).","journal-title":"Biol. Psychiatry"},{"key":"603_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neubiorev.2020.06.004","volume":"116","author":"I B\u00e8gue","year":"2020","unstructured":"B\u00e8gue, I., Kaiser, S. & Kirschner, M. Pathophysiology of negative symptom dimensions of schizophrenia\u2014current developments and implications for treatment. Neurosci. Biobehav. Rev. 116, 74\u201388 (2020).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"603_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrn.2017.125","volume":"18","author":"R Birnbaum","year":"2017","unstructured":"Birnbaum, R. & Weinberger, D. R. Genetic insights into the neurodevelopmental origins of schizophrenia. Nat. Rev. Neurosci. 18, 727\u2013740 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"603_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.biopsych.2020.03.008","volume":"89","author":"J Richetto","year":"2021","unstructured":"Richetto, J. & Meyer, U. Epigenetic modifications in schizophrenia and related disorders: molecular scars of environmental exposures and source of phenotypic variability. Biol. Psychiatry 89, 215\u2013226 (2021).","journal-title":"Biol. Psychiatry"},{"key":"603_CR14","doi-asserted-by":"publisher","unstructured":"St\u0119pnicki, P., Kondej, M. & Kaczor, A. A. Current concepts and treatments of schizophrenia. molecules (Basel, Switzerland). https:\/\/doi.org\/10.3390\/molecules23082087 (2018).","DOI":"10.3390\/molecules23082087"},{"key":"603_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biopsych.2016.07.014","volume":"81","author":"OD Howes","year":"2017","unstructured":"Howes, O. D., McCutcheon, R., Owen, M. J. & Murray, R. M. The role of genes, stress, and dopamine in the development of schizophrenia. Biol. Psychiatry 81, 9\u201320 (2017).","journal-title":"Biol. Psychiatry"},{"key":"603_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrn.2015.19","volume":"17","author":"GE Hardingham","year":"2016","unstructured":"Hardingham, G. E. & Do, K. Q. Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis. Nat. Rev. Neurosci. 17, 125\u2013134 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"603_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107426","volume":"205","author":"K Nakazawa","year":"2020","unstructured":"Nakazawa, K. & Sapkota, K. The origin of NMDA receptor hypofunction in schizophrenia. Pharm. Ther. 205, 107426 (2020).","journal-title":"Pharm. Ther."},{"key":"603_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.schres.2014.12.026","volume":"167","author":"SM Cohen","year":"2015","unstructured":"Cohen, S. M., Tsien, R. W., Goff, D. C. & Halassa, M. M. The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia. Schizophr. Res. 167, 98\u2013107 (2015).","journal-title":"Schizophr. Res."},{"key":"603_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9983438","volume":"2021","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Molecular basis of GABA hypofunction in adolescent schizophrenia-like animals. Neural Plast. 2021, 9983438 (2021).","journal-title":"Neural Plast."},{"key":"603_CR20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/0306-9877(80)90087-0","volume":"6","author":"SA Barker","year":"1980","unstructured":"Barker, S. A., Carl, G. F. & Monti, J. A. Hyperformaldehydism: a unifying hypothesis for the major biochemical theories of schizophrenia. Med Hypotheses 6, 671\u2013686 (1980).","journal-title":"Med Hypotheses"},{"key":"603_CR21","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.chemosphere.2015.10.102","volume":"144","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Effects of formaldehyde exposure on anxiety-like and depression-like behavior, cognition, central levels of glucocorticoid receptor and tyrosine hydroxylase in mice. Chemosphere 144, 2004\u20132012 (2016).","journal-title":"Chemosphere"},{"key":"603_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.bbi.2024.02.004","volume":"117","author":"D Zhao","year":"2024","unstructured":"Zhao, D. et al. Midbrain FA initiates neuroinflammation and depression onset in both acute and chronic LPS-induced depressive model mice. Brain Behav. Immun. 117, 356\u2013375 (2024).","journal-title":"Brain Behav. Immun."},{"key":"603_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s42003-019-0694-x","volume":"2","author":"L Ai","year":"2019","unstructured":"Ai, L. et al. Endogenous formaldehyde is a memory-related molecule in mice and humans. Commun. Biol. 2, 446 (2019).","journal-title":"Commun. Biol."},{"key":"603_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101512","volume":"73","author":"Y Kou","year":"2022","unstructured":"Kou, Y., Zhao, H., Cui, D., Han, H. & Tong, Z. Formaldehyde toxicity in age-related neurological dementia. Ageing Res. Rev. 73, 101512 (2022).","journal-title":"Ageing Res. Rev."},{"key":"603_CR25","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1126\/science.175.4027.1269","volume":"175","author":"G Cohen","year":"1972","unstructured":"Cohen, G., Mytilineou, G. & Barrett, R. E. 6,7-Dihydroxytetrahydroisoquinoline: uptake and storage by peripheral sympathetic nerve of the rat. Science 175, 1269\u20131272 (1972).","journal-title":"Science"},{"key":"603_CR26","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/0091-3057(81)90125-8","volume":"14","author":"EC Makowski","year":"1981","unstructured":"Makowski, E. C. & Ordo\u00f1ez, L. A. Behavioral alterations induced by formaldehyde-derived tetrahydroisoquinolines. Pharmacol. Biochem. Behav. 14, 639\u2013643 (1981).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"603_CR27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.neuroscience.2008.08.050","volume":"156","author":"E Lorenc-Koci","year":"2008","unstructured":"Lorenc-Koci, E. et al. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats. Neuroscience 156, 973\u2013986 (2008).","journal-title":"Neuroscience"},{"key":"603_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0006-8993(93)91594-I","volume":"619","author":"B Glenth\u00f8j","year":"1993","unstructured":"Glenth\u00f8j, B., Mogensen, J., Laursen, H., Holm, S. & Hemmingsen, R. Electrical sensitization of the meso-limbic dopaminergic system in rats: a pathogenetic model for schizophrenia. Brain Res. 619, 39\u201354 (1993).","journal-title":"Brain Res."},{"key":"603_CR29","first-page":"290","volume":"481","author":"HZ Niu","year":"2006","unstructured":"Niu, H. Z., Wang, L., Zhong, W. Z., Chen, D. & Yu, W. Study of animal model of schizophrenia by electrical stimulation in rats. Qilu Med. J. 481, 290\u2013292 (2006).","journal-title":"Qilu Med. J."},{"key":"603_CR30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.nucmedbio.2012.01.005","volume":"39","author":"YR Huang","year":"2012","unstructured":"Huang, Y. R. et al. [123I]Epidepride neuroimaging of dopamine D2\/D3 receptor in chronic MK-801-induced rat schizophrenia model. Nucl. Med. Biol. 39, 826\u2013832 (2012).","journal-title":"Nucl. Med. Biol."},{"key":"603_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.pbb.2003.11.002","volume":"77","author":"CD Cook","year":"2004","unstructured":"Cook, C. D., Newman, J. L., Winfree, J. C. & Beardsley, P. M. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2\/3 receptor agonists in mice. Pharmacol. Biochem. Behav. 77, 309\u2013318 (2004).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"603_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1101\/lm.1339109","volume":"16","author":"DJ Sanderson","year":"2009","unstructured":"Sanderson, D. J. et al. Enhanced long-term and impaired short-term spatial memory in GluA1 AMPA receptor subunit knockout mice: evidence for a dual-process memory model. Learn Mem. 16, 379\u2013386 (2009).","journal-title":"Learn Mem."},{"key":"603_CR33","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1038\/s41380-020-00929-7","volume":"26","author":"X Fei","year":"2021","unstructured":"Fei, X. et al. Degradation of FA reduces Abeta neurotoxicity and Alzheimer-related phenotypes. Mol. Psychiatry 26, 5578\u20135591 (2021).","journal-title":"Mol. Psychiatry"},{"key":"603_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0003-2697(03)00211-2","volume":"318","author":"PH Yu","year":"2003","unstructured":"Yu, P. H., Cauglin, C., Wempe, K. L. & Gubisne-Haberle, D. A novel sensitive high-performance liquid chromatography\/electrochemical procedure for measuring formaldehyde produced from oxidative deamination of methylamine and in biological samples. Anal. Biochem. 318, 285\u2013290 (2003).","journal-title":"Anal. Biochem."},{"key":"603_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000371580","volume":"95","author":"H Chiba","year":"2015","unstructured":"Chiba, H. et al. Effects of 1,2,3,4-tetrahydroisoquinoline derivatives on dopaminergic spontaneous discharge in substantia nigra neurons in rats. Pharmacology 95, 87\u201394 (2015).","journal-title":"Pharmacology"},{"key":"603_CR36","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0006-2952(02)01353-9","volume":"64","author":"F De Marco","year":"2002","unstructured":"De Marco, F. et al. Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells. Biochem. Pharm. 64, 1503\u20131512 (2002).","journal-title":"Biochem. Pharm."},{"key":"603_CR37","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1046\/j.1471-4159.2001.00619.x","volume":"79","author":"K Ishiwata","year":"2001","unstructured":"Ishiwata, K. et al. Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum. J. Neurochem. 79, 868\u2013876 (2001).","journal-title":"J. Neurochem."},{"key":"603_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28190-2","volume":"13","author":"G Qi","year":"2022","unstructured":"Qi, G. et al. NAc-VTA circuit underlies emotional stress-induced anxiety-like behavior in the three-chamber vicarious social defeat stress mouse model. Nat. Commun. 13, 577 (2022).","journal-title":"Nat. Commun."},{"key":"603_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/jnc.12356","volume":"127","author":"K Tulpule","year":"2013","unstructured":"Tulpule, K. & Dringen, R. Formaldehyde in brain: an overlooked player in neurodegeneration? J. Neurochem. 127, 7\u201321 (2013).","journal-title":"J. Neurochem."},{"key":"603_CR40","first-page":"671","volume":"19","author":"S Sayad-Fathi","year":"2020","unstructured":"Sayad-Fathi, S. et al. The methanolic extract of Cinnamomum zeylanicum bark improves formaldehyde-induced neurotoxicity through reduction of phospho-tau (Thr231), inflammation, and apoptosis. EXCLI J. 19, 671\u2013686 (2020).","journal-title":"EXCLI J."},{"key":"603_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/1178646917691938","volume":"10","author":"AA Badawy","year":"2017","unstructured":"Badawy, A. A. Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects. Int. J. Tryptophan Res. 10, 1178646917691938 (2017).","journal-title":"Int. J. Tryptophan Res."},{"key":"603_CR42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/npp.2016.143","volume":"42","author":"JC Felger","year":"2017","unstructured":"Felger, J. C. & Treadway, M. T. Inflammation effects on motivation and motor activity: role of dopamine. Neuropsychopharmacology 42, 216\u2013241 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"603_CR43","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes, M., Leonard, B. E., Myint, A. M., Kubera, M. & Verkerk, R. The new \u20185-HT\u2019 hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 702\u2013721 (2011).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"603_CR44","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0197-0186(00)00121-2","volume":"38","author":"Y Maruyama","year":"2001","unstructured":"Maruyama, Y., Teraoka, H., Iwata, H., Kazusaka, A. & Fujita, S. Inhibitory effects of endogenous dopaminergic neurotoxin, norsalsolinol on dopamine secretion in PC12 rat pheochromocytoma cells. Neurochem. Int. 38, 567\u2013572 (2001).","journal-title":"Neurochem. Int."},{"key":"603_CR45","first-page":"567","volume":"54","author":"L Antkiewicz-Michaluk","year":"2002","unstructured":"Antkiewicz-Michaluk, L. Endogenous risk factors in Parkinson\u2019s disease: dopamine and tetrahydroisoquinolines. Pol. J. Pharmacol. 54, 567\u2013572 (2002).","journal-title":"Pol. J. Pharmacol."},{"key":"603_CR46","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1248\/bpb.28.1355","volume":"28","author":"K Abe","year":"2005","unstructured":"Abe, K., Saitoh, T., Horiguchi, Y., Utsunomiya, I. & Taguchi, K. Synthesis and neurotoxicity of tetrahydroisoquinoline derivatives for studying Parkinson\u2019s disease. Biol. Pharm. Bull. 28, 1355\u20131362 (2005).","journal-title":"Biol. Pharm. Bull."},{"key":"603_CR47","doi-asserted-by":"publisher","first-page":"15583","DOI":"10.1021\/acs.jafc.2c06538","volume":"70","author":"J Ou","year":"2022","unstructured":"Ou, J., Hu, J. & Ou, S. Cytotoxicity of a novel compound produced in foods via the reaction of amino acids with acrolein along with formaldehyde. J. Agric. Food Chem. 70, 15583\u201315592 (2022).","journal-title":"J. Agric. Food Chem."},{"key":"603_CR48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1006\/taap.2001.9154","volume":"172","author":"GS Ratra","year":"2001","unstructured":"Ratra, G. S., Kamita, S. G. & Casida, J. E. Role of human GABA(A) receptor beta3 subunit in insecticide toxicity. Toxicol. Appl. Pharm. 172, 233\u2013240 (2001).","journal-title":"Toxicol. Appl. Pharm."},{"key":"603_CR49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2213120119","volume":"119","author":"SK Jones","year":"2022","unstructured":"Jones, S. K. et al. Transgenerational transmission of aspartame-induced anxiety and changes in glutamate-GABA signaling and gene expression in the amygdala. Proc. Natl Acad. Sci. USA 119, e2213120119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"603_CR50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biopsych.2016.05.021","volume":"81","author":"TV Maia","year":"2017","unstructured":"Maia, T. V. & Frank, M. J. An integrative perspective on the role of dopamine in schizophrenia. Biol. Psychiatry 81, 52\u201366 (2017).","journal-title":"Biol. Psychiatry"},{"key":"603_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02800-7","volume":"14","author":"Q Wu","year":"2024","unstructured":"Wu, Q. et al. Prefrontal cortical dopamine deficit may cause impaired glucose metabolism in schizophrenia. Transl. Psychiatry 14, 79 (2024).","journal-title":"Transl. Psychiatry"},{"key":"603_CR52","doi-asserted-by":"publisher","unstructured":"Gender differences in schizophrenia. Am. J. Psychiatry https:\/\/doi.org\/10.1176\/ajp.148.12.1754c (1991).","DOI":"10.1176\/ajp.148.12.1754c"}],"container-title":["Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00603-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T09:21:39Z","timestamp":1743326499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00603-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1038\/s41537-025-00603-3","relation":{},"ISSN":["2754-6993"],"issn-type":[{"value":"2754-6993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"15 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}